Inhaled glucocorticosteroid treatment effects on pulmonary artery pressure and cardiac function in healthy smokers

Conclusion: The study findings suggest that ICS treatment of persons, who by virtue of their smoking history are at greater cardiovascular risk, may receive a cardiovascular benefit of ICS treatment evidenced by improved resting cardiac function and an enhanced hemodynamic response to vasodilatory challenge.Supported by a grant from Glaxo-Smith-Kline.

Source: European Respiratory Journal - November 7, 2016 Category: Respiratory Medicine Authors: Mendes, E., Wanner, A., Parker, M., Schmid, A., Arana, J., Hurwitz, B. Tags: 4.3 Pulmonary Circulation and Pulmonary Vascular Diseases Source Type: research